Last reviewed · How we verify
NCT04011696: MERoV
Monofocal Extended Range of Vision (MERoV) Study
trial in Pseudophakia in 412 participants. Completed in 31 May 2022.
31 May 2022
Quick facts
| Lead sponsor | Brighton and Sussex University Hospitals NHS Trust |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 412 |
| Start date | 3 July 2019 |
| Primary completion | 31 May 2022 |
| Estimated completion | 31 May 2022 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Pseudophakia — all drugs for Pseudophakia →
- Accomodation — all drugs for Accomodation →
- Aberration, Corneal Wavefront — all drugs for Aberration, Corneal Wavefront →
Sponsor
Brighton and Sussex University Hospitals NHS Trust
Who can join
18 and older, any sex, with Pseudophakia or Accomodation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators are proposing this research project to: 1. Screen a set of patients after normal cataract surgery with a single focus lens aimed at good distance vision at 3 months after surgery to identify patients who are able to see and read well without glasses. 2. Identify the combination of factors responsible for this phenomenon in the patients who are achieving this. Potentially eligible patients will be given an invitation letter and patient information sheet on the day they arrive for surgery. They will then be asked if they are happy to be contacted by phone 2-4 weeks post-surgery with a view to booking them into an additional research visit at 3 months after their surgery. At 3 months after surgery they will have their un-corrected vision checked. They will also have their reading speed assessed without any glasses. They will undergo a through refractive check by an optometrist to assess the power of the spectacles (if needed) and following this they will have a scan of the eye (a technique known as wave front analysis which uses very sophisticated optics) to capture the optical distortions in the structures of the eye. If this study is able identify factor/s responsible for giving good unaided reading and distance vision then this factor can be reproduced in eyes undergoing cataract surgery. This will mean that the patients can have an increased option of spectacle independence without the need for expensive multifocal IOLs and their associated side effects such as glare and halos, particularly at night.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Incidence and factors for pseudoaccommodation after monofocal lens implantation: the Monofocal Extended Range of Vision study.
Nanavaty MA, Mukhija R, Ashena Z, Bunce C, et al · · 2023 · cited 9× · PMID 37769187 · DOI 10.1097/j.jcrs.0000000000001302 -
Unaided reading speed in pseudophakic patients after emmetropic monofocal intraocular lens implantation.
Nanavaty MA, Mukhija R, Ashena Z, Bunce C, et al · · 2025 · PMID 41131330 · DOI 10.1038/s41433-025-04048-x
Verify or expand the search:
- PubMed search for NCT04011696
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pseudophakia
Currently open trials in the same condition.
- NCT04692012 — Treatment of Residual Hypermetropic Refraction on Pseudophakic Patients Using Allogenic Fresh Myopic Lenticule · NA · active not recruiting
Other Brighton and Sussex University Hospitals NHS Trust trials
Trials by the same sponsor.
- NCT06120946 — Neurocognitive Assessment in TAVI · completed
- NCT05287269 — Ocular Coherence Tomography During Cataract Assessment · completed
- NCT04175951 — Tecnis Eyhance Versus Rayner RayOne Study · NA · unknown
- NCT05671016 — Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy · completed
- NCT03411889 — A Feasibility Study to Develop a Protocol for Functional Lacrimal Magnetic Resonance Imaging · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04011696 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brighton and Sussex University Hospitals NHS Trust
- Last refreshed: 3 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04011696.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing